샘플 요청 목록

 카트 문의
시장보고서
상품코드
1944464

전임상 이미징 시장 : 제품 종류별, 모달리티별, 용도별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Preclinical Imaging Market, By Product Type, By Modality, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 348 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

전임상 이미징 시장 규모는 2024년에 9억 9,598만 달러로 평가되었으며, 2025년부터 2032년까지 CAGR 5.54%로 확대될 전망입니다.

전임상 이미징 시장에는 인체 시험 전 동물 모델에서 질병 및 약효를 조사하기 위해 사용되는 기기, 조영제, 소프트웨어가 포함됩니다. 이러한 도구는 종양, 장기, 생물학적 활성을 반복적이고 비침습적으로 추적할 수 있기 때문에 신약개발에 있어 신속하고 확실한 의사결정을 지원하는 초기 연구에 매우 중요합니다. 일반적인 이미징 기법으로는 상세한 해부구조 관찰을 위한 마이크로 CT, 마이크로 MRI, 기능적, 분자적 신호 분석을 위한 PET, SPECT, 형광 프로브나 생물발광 프로브를 이용한 신속한 스크리닝을 위한 광학 이미징 등이 있습니다. 연구 품질 향상을 위해 여러 방법을 조합하고 있습니다. 수요는 종양학, 신경학, 감염병 연구 등의 분야와 더불어 보다 우수한 생체 내 작용기전 증명 및 생체 내 분포 분석을 필요로 하는 생물학적 제제 및 첨단 치료법의 성장과 연동되어 있습니다.

제약회사, CRO, 연구기관 등 구매자의 주요 관심사는 일반적으로 이미지 품질, 감도, 워크플로우 속도, 정량화 및 보고용 소프트웨어, 프로브 및 트레이서와의 호환성, 서비스 지원, 시스템 운영의 전체 라이프사이클에 걸친 총 비용입니다. 이 시장이 중요한 이유는 우수한 전임상 이미징을 통해 개발 초기 단계의 불확실성을 줄이고, 파이프라인 후반부의 값비싼 실패를 방지할 수 있기 때문입니다.

전임상 이미징 시장 역학

정부 지원의 강력한 생의학 연구와 대규모 임상 파이프라인이 전임상 영상 데이터에 대한 수요를 증가시키고 있습니다.

전임상 이미징에 대한 수요 증가의 배경에는 바이오메디컬 연구 자금의 증가와 수많은 의약품 개발 프로그램이 존재합니다. 특히 생물학적 분포와 반응 모니터링이 중요한 종양학, 신경과학, 첨단 치료 분야에서 고비용의 임상시험 단계에 들어가기 전에 확실한 생체 내 증거를 확보해야 합니다. 미국 국립과학재단(NSF)에 따르면, 2022년 미국의 R&D 총 지출은 약 8,920억 달러에 달할 것으로 예상되며, 이는 실험실 운영, CRO 업무, 장비 구매를 지원하는 R&D 활동의 전체 규모를 나타냅니다. 보건 분야 연구에서는 미국 국립보건원(NIH)의 예산 권한이 2023 회계연도에 약 475억 달러, 2024 회계연도에 약 480억 달러로 책정되어 있으며, 이는 많은 전임상 연구를 뒷받침하고 있습니다. 이러한 연구에서 소동물 이미징은 시간 경과에 따른 분석을 위해 자주 활용되고 있습니다. 임상 개발 파이프라인의 규모도 지속적인 전임상 수요를 시사하고 있습니다. ClinicalTrials.gov(미국 국립의학도서관)에 따르면, 2024년부터 2025년까지 50만 건 이상의 연구가 등록되어 있으며, 많은 프로그램이 진행되기 전에 이미징 기술을 통한 개념증명(PoC), 표적 결합, 안전성 데이터를 뒷받침하는 광범위한 파이프라인이 존재한다는 것을 보여줍니다. 파이프라인이 존재함을 보여주고 있습니다. 이러한 공개 지표는 시장의 실질적인 구매 요인을 보여줍니다. 안정적인 자금 조달과 지속적인 파이프라인 활동으로 재현성 있는 결과, 연구 기간 단축, 명확한 지속/중단 판단을 가능하게 하는 이미징 시스템, 프로브, 소프트웨어에 대한 지속적인 수요가 창출되고 있습니다.

전임상 이미징 시장 : 세분화 분석

전임상 이미징에 대한 수요는 의약품 개발 파이프라인의 가동 상황 및 공공 연구 자금의 규모와 밀접한 관련이 있습니다. 활동이 활발해질수록 측정 가능한 생체 내 결과를 필요로 하는 동물 실험이 증가하기 때문입니다. 파이프라인의 규모를 파악할 수 있는 간단한 방법은 임상시험 등록 건수를 통해 확인할 수 있습니다. 미국 국립 의학 도서관의 ClinicalTrials.gov 데이터베이스에 따르면, 2024년부터 2025년까지 50만 건 이상의 연구가 등록되어 있으며, 이는 일반적으로 전진하기 전에 강력한 전임상 데이터 패키지를 필요로 하는 안정적인 세계 개발 활동을 보여줍니다. 연구 차원에서도 자금은 비슷한 추세를 뒷받침하고 있습니다. 미국 국립보건원(NIH)에 따르면, 2023년 NIH의 예산 권한은 약 475억 달러, 2024년 약 480억 달러로 종양학, 신경학, 감염학 연구의 광범위한 기반을 유지하고 있습니다. 이러한 분야에서 소동물 이미징은 시간 경과에 따른 추적 및 치료 반응 측정에 자주 활용되고 있습니다. 유럽에서도 광범위한 연구개발(R&D)이 활발하게 진행되고 있습니다. 유로스타트에 따르면, EU의 국내 총 연구개발비는 2022년부터 2023년까지 GDP의 2% 이상을 유지하여 대학 및 연구기관의 지속적인 장비 수요를 뒷받침하고 있습니다.

연구에서의 기술적 요구도 구매 결정에 영향을 미칩니다. 특히 구조적 세부 사항과 기능적, 분자적 분석 결과를 모두 필요로 하는 연구에서 복합 이미징 워크플로우의 채택이 증가하면서 분석 소프트웨어에 대한 수요가 증가하고 있습니다. 추적자를 이용한 연구는 핵의학의 능력과 동위원소 공급에 의존하고 있으며, 이는 전임상 PET/SPECT 활동과 광범위한 핵의학 인프라를 연결하고 있습니다. 국제원자력기구(IAEA)에 따르면, 설치된 이미징 시스템 및 관련 인프라의 성장이 보고되고 있는 가운데, 핵의학 역량은 2020년대 초까지 회원국 전체에서 확대되어 분자 이미징 워크플로우에 필요한 생태계 구축에 기여하고 있습니다. 이와 함께 조사 프로그램의 일관성과 문서화에 대한 기대치가 높아짐에 따라 재현성 있는 스캔, 높은 가동률, 표준화된 보고서 제공이 가능한 시스템에 대한 요구가 증가하고 있습니다. 특히 조사 간 처리량과 데이터 비교가능성이 중요한 CRO 스타일의 환경에서 이러한 경향이 두드러집니다.

전임상 이미징 시장 - 지역별 분석

전임상 이미징 활동은 일반적으로 바이오메디컬 연구개발비가 풍부한 지역, 대규모 대학 및 병원 연구 네트워크, 안정적인 의약품 개발 파이프라인을 보유한 지역에서 가장 활발하게 이루어지고 있습니다. 이에 따라 이미징 시스템, 프로브, 분석 소프트웨어에 대한 수요가 안정적으로 유지되고 있습니다. 북미는 공공 연구 예산의 규모가 크고 안정적이기 때문에 여전히 중요한 시장입니다. 미국 국립보건원(NIH)에 따르면, 2023년도 NIH 예산 권한은 약 475억 달러, 2024년도에는 약 480억 달러로 암, 신경과학, 감염질환 분야에서 영상 분석을 많이 사용하는 많은 프로그램을 지원하고 있습니다. 유럽에서도 연구 활동은 지속적으로 활발하게 진행되고 있습니다. 유로스타트에 따르면, EU의 2022-2023년 연구개발(R&D) 총지출은 GDP 대비 2% 이상을 유지하고 있으며, 학술기관 및 정부 연구기관의 장비 구매 및 시설 업데이트가 지속적으로 이루어지고 있습니다. 파이프라인 규모도 지속적인 수요를 나타내는 지표입니다. ClinicalTrials.gov(미국 국립의학도서관)에 따르면, 2024-2025년 등록되는 연구는 50만 건 이상이며, 이는 전임상 데이터와 번역 바이오마커 연구에 의존하는 대규모 개발 파이프라인이 존재한다는 것을 의미합니다.

미국 전임상 이미징 시장 - 국가별 분석

미국은 생물의학 연구 자금 기반이 두텁고, 활발한 연구기관이 많으며, 중개연구가 제약, 바이오테크놀러지, CRO(위탁연구기관)의 활동과 밀접하게 연계되어 있어 단일 국가로는 가장 강력한 시장입니다. 가장 직접적인 촉진요인은 공적 자금입니다. 미국 국립보건원(NIH)에 따르면, 2024년 연간 예산 권한은 약 480억 달러로 유지되고 있으며, 이는 소동물 이미징 플랫폼 및 관련 소모품에 대한 지속적인 수요를 뒷받침하고 있습니다. 미국 국립과학재단(NSF)에 따르면, 2022년 미국의 총 R&D 지출은 약 8,920억 달러에 달할 것으로 예상되며, 이는 고급 장비와 전문적 워크플로우에 대한 강한 수요를 보여줍니다. 의약품 개발 활동은 또 다른 수요층을 형성하고 있습니다. ClinicalTrials.gov(미국 국립의학도서관)에 따르면, 2024년부터 2025년까지 등록된 연구는 50만 건을 넘어섰으며, 이는 임상시험 실시 전 이미징 기반 개념증명, 생체 내 분포 연구, 반응 모니터링에 대한 지속적인 수요와 일치합니다.

목차

제1장 전임상 이미징 시장 개요

제2장 주요 요약

제3장 전임상 이미징의 주요 시장 동향

제4장 전임상 이미징 시장 : 산업 분석

제5장 전임상 이미징 시장 : 높아지는 지정학적 긴장의 영향

제6장 전임상 이미징 시장 구도

제7장 전임상 이미징 시장 : 제품 종류별

제8장 전임상 이미징 시장 : 모달리티별

제9장 전임상 이미징 시장 : 용도별

제10장 전임상 이미징 시장 : 최종사용자별

제11장 전임상 이미징 시장 : 지역별

제12장 주요 벤더 분석 : 전임상 이미징 산업

제13장 애널리스트의 전방위적 전망

KSM

Preclinical Imaging Market size was valued at US$ 995.98 Million in 2024, expanding at a CAGR of 5.54% from 2025 to 2032.

The preclinical imaging market includes the equipment, imaging agents, and software used to study diseases and drug effects in live animal models before human trials. These tools are important in early research because they allow repeated, non-invasive tracking of tumors, organs, or biological activity over time, which supports faster and more confident decisions in drug discovery. Common imaging options include micro-CT and micro-MRI for detailed anatomy, PET and SPECT for functional or molecular signals, and optical imaging for quick screening using fluorescent or bioluminescent probes, with many labs combining more than one method to improve study quality. Demand is linked to areas like oncology, neurology, and infectious disease research, plus the growth of biologics and advanced therapies that need better in vivo proof of mechanism and biodistribution.

For buyers such as pharma companies, CROs, and research institutes, the main focus is usually on image quality, sensitivity, workflow speed, software for quantification and reporting, compatibility with probes and tracers, service support, and the overall cost of running the system over its lifetime. This market matters because better preclinical imaging can reduce uncertainty earlier in development and help avoid expensive failures later in the pipeline.

Preclinical Imaging Market- Market Dynamics

Strong government-funded biomedical research and a large clinical pipeline are increasing the need for preclinical imaging data

Preclinical imaging demand is rising because more biomedical research funding and a large flow of drug programs require solid in vivo evidence before expensive clinical steps, especially for oncology, neuroscience, and advanced therapies, where biodistribution and response monitoring are critical. According to the U.S. National Science Foundation (NSF), total U.S. research and development spending reached about USD 892 billion in 2022, showing the overall scale of R&D activity that supports labs, CRO work, and equipment purchasing. In health-focused research, according to the National Institutes of Health (NIH), NIH budget authority was around USD 47.5 billion in FY2023 and about USD 48.0 billion in FY2024, which supports a large number of preclinical studies that often rely on small-animal imaging for longitudinal readouts. The size of the clinical development funnel also signals ongoing preclinical demand; According to ClinicalTrials.gov (U.S. National Library of Medicine), the registry listed more than 500,000 studies during 2024-2025, indicating a broad pipeline where many programs need imaging-backed proof-of-concept, target engagement, and safety support before moving forward. These public indicators point to a practical buying driver in the market: stable funding and steady pipeline activity create ongoing need for imaging systems, probes, and software that can deliver repeatable results, faster study timelines, and clearer go/no-go decisions.

Preclinical Imaging Market- Segmentation Analysis:

Preclinical imaging demand is closely tied to how busy the drug development pipeline is and how much public research funding is available, because higher activity creates more animal studies that need measurable in vivo results. A simple way to see the pipeline scale is through trial registration volume; according to ClinicalTrials.gov (U.S. National Library of Medicine), the database listed more than 500,000 studies during 2024-2025, which signals steady global development work that usually requires stronger preclinical packages before moving forward. Funding also supports the same trend at the research level; according to the National Institutes of Health (NIH), NIH budget authority was about USD 47.5 billion in FY2023 and around USD 48.0 billion in FY2024, keeping a large base of oncology, neurology, and infectious disease research active, where small-animal imaging is often used for longitudinal tracking and treatment response measurement. In Europe, broad R&D intensity has also been maintained; according to Eurostat, EU gross domestic expenditure on R&D stayed above 2% of GDP in 2022-2023, which supports continued equipment demand from universities and research institutes.

Technology needs inside studies also shape buying decisions, especially when a study requires both structural detail and functional or molecular readouts, which pushes more combined imaging workflows and more demand for analysis software. Tracer-based work depends on nuclear medicine capacity and isotope supply, which connects preclinical PET/SPECT activity with wider nuclear medicine infrastructure. According to the International Atomic Energy Agency (IAEA), nuclear medicine capability expanded across member states through the early 2020s, supported by reported growth in installed imaging systems and related infrastructure, which helps build the ecosystem needed for molecular imaging workflows. Alongside this, stronger expectations around consistency and documentation in research programs are increasing demand for systems that can deliver repeatable scans, higher uptime, and standardized reporting, especially in CRO-style environments where throughput and data comparability across studies matter.

Preclinical Imaging Market- Geographical Insights

Preclinical imaging activity is usually strongest in regions with high biomedical R&D spending, large university and hospital research networks, and steady drug development pipelines, which keeps demand consistent for imaging systems, probes, and analysis software. North America remains important because public research budgets are large and stable; according to the National Institutes of Health (NIH), NIH budget authority was about USD 47.5 billion in FY2023 and about USD 48.0 billion in FY2024, supporting many imaging-heavy programs in cancer, neuroscience, and infectious disease. Europe also shows sustained research intensity; according to Eurostat, EU gross domestic expenditure on R&D stayed above 2% of GDP in 2022-2023, which supports continued equipment purchasing and facility upgrades in academic and government research institutes. Pipeline scale is another indicator of ongoing demand; according to ClinicalTrials.gov (U.S. National Library of Medicine), the registry listed more than 500,000 studies during 2024-2025, which signals a large development funnel that depends on preclinical evidence and translational biomarker work.

United States Preclinical Imaging Market- Country Insights

The United States is the strongest single-country market because the funding base for biomedical research is large, the number of active research organizations is high, and translational work is closely linked to pharma, biotech, and CRO activity. The most direct driver is public funding; according to the National Institutes of Health (NIH), annual budget authority stayed near USD 48 billion in FY2024, which supports continuous demand for small-animal imaging platforms and related consumables. The broader research environment is also large; according to the U.S. National Science Foundation (NSF), total U.S. spending on research and development reached about USD 892 billion in 2022, showing strong capacity for high-end instruments and specialized workflows. Drug development activity adds another demand layer; according to ClinicalTrials.gov (U.S. National Library of Medicine), registered studies exceeded 500,000 during 2024-2025, which aligns with ongoing needs for imaging-based proof-of-concept, biodistribution studies, and response monitoring before clinical commitments.

Preclinical Imaging Market- Competitive Landscape:

The preclinical imaging vendor landscape is usually discussed by modality strengths and workflow integration, because buyers tend to compare resolution, sensitivity, throughput, software quantification, and service support across platforms. Bruker Corporation is commonly referenced for preclinical MRI and micro-CT systems and integrated imaging workflows for research labs. Revvity, Inc. is frequently associated with optical imaging and reagent ecosystems used for fast in vivo screening and longitudinal monitoring. FUJIFILM VisualSonics Inc. is often linked to high-resolution preclinical ultrasound and photoacoustic imaging used in cardiovascular and oncology research. For nuclear imaging workflows, MILabs B.V. and Mediso Ltd. are typically cited for preclinical PET/SPECT systems and multi-modal configurations that support tracer-based studies. Larger imaging groups such as Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., and Canon Medical Systems Corporation are also referenced in the space due to strengths in imaging technology and software that support translational collaborations. Public demand signals explain why competition stays active; according to NIH and according to ClinicalTrials.gov (U.S. National Library of Medicine), the scale of research funding and the large pipeline of studies supports continued investment in higher-throughput systems, standardized analysis tools, and multi-modality imaging setups.

Recent Developments:

In October 2025, The START Center for Cancer Research, an oncology-focused clinical research organization, along with its preclinical division XenoSTART, and Minerva Imaging, a radiopharmaceutical CRO/CDMO specializing in molecular imaging and radionuclide therapy, expanded their long-running partnership to build an integrated platform for radiopharmaceutical drug development by combining clinically annotated patient-derived xenograft (PDX) models with advanced imaging capabilities such as PET/CT, SPECT/CT, and MRI plus GMP manufacturing, aiming to shorten timelines and reduce development risk for oncology radiopharmaceutical programs.

In September 2025, Revvity, Inc., a provider of health science solutions and preclinical imaging tools, launched Living Image(TM) Synergy AI, a multimodal in vivo imaging analysis software platform designed to unify data analysis across optical, microCT, ultrasound, and other modalities; the software adds AI-based automation for tasks such as image segmentation and ROI quantification to reduce manual work, improve throughput, and enhance reproducibility, and it was scheduled to be showcased at the WMIC conference in late September 2025.

In September 2023, Revvity, Inc., a supplier of preclinical imaging systems and workflow solutions, expanded its imaging portfolio with the launch of the next-generation IVIS(R) Spectrum 2 and IVIS SpectrumCT 2 optical imaging systems, the Quantum(TM) GX3 microCT solution, and the global debut of the Vega(R) ultrasound system, targeting higher sensitivity, resolution, and faster throughput for in vivo and ex vivo preclinical research workflows and presenting the systems at the World Molecular Imaging Congress (WMIC) in Prague.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PRECLINICAL IMAGING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Aspect Imaging Ltd.
  • BIONANO GENOMICS, INC.
  • Biospace Lab S.A.
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • CubiX Imaging, Inc.
  • FUJIFILM VisualSonics Inc.
  • GE HealthCare Technologies Inc.
  • Mediso Ltd.
  • MILabs B.V.
  • MinFound Medical Systems Co., Ltd.
  • MR Solutions Group Ltd.
  • Nanoscan Imaging Ltd.
  • PerkinElmer Inc.
  • Philips International B.V.
  • Revvity, Inc.
  • Siemens Healthineers AG
  • Sofie Biosciences, Inc.
  • TriFoil Imaging, Inc.
  • Trifoil Imaging, Inc.
  • Others

GLOBAL PRECLINICAL IMAGING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Imaging Systems
  • Reagents & Probes/Contrast Agents
  • Software & Services

GLOBAL PRECLINICAL IMAGING MARKET, BY MODALITY- MARKET ANALYSIS, 2019 - 2032

  • Optical Imaging
  • MRI
  • CT
  • PET
  • SPECT
  • Ultrasound
  • Photoacoustic Imaging

GLOBAL PRECLINICAL IMAGING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Neurology
  • Cardiology
  • Infectious Diseases
  • Others

GLOBAL PRECLINICAL IMAGING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic & Research Institutes
  • Others

GLOBAL PRECLINICAL IMAGING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Preclinical Imaging Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Preclinical Imaging Market Snippet by Product Type
    • 2.1.2. Preclinical Imaging Market Snippet by Modality
    • 2.1.3. Preclinical Imaging Market Snippet by Application
    • 2.1.4. Preclinical Imaging Market Snippet by End User
    • 2.1.5. Preclinical Imaging Market Snippet by Country
    • 2.1.6. Preclinical Imaging Market Snippet by Region
  • 2.2. Competitive Insights

3. Preclinical Imaging Key Market Trends

  • 3.1. Preclinical Imaging Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Preclinical Imaging Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Preclinical Imaging Market Opportunities
  • 3.4. Preclinical Imaging Market Future Trends

4. Preclinical Imaging Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Preclinical Imaging Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Preclinical Imaging Market Landscape

  • 6.1. Preclinical Imaging Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Preclinical Imaging Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Imaging Systems
    • 7.1.3. Reagents & Probes/Contrast Agents
    • 7.1.4. Software & Services

8. Preclinical Imaging Market - By Modality

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Modality, 2024 & 2032 (%)
    • 8.1.2. Optical Imaging
    • 8.1.3. MRI
    • 8.1.4. CT
    • 8.1.5. PET
    • 8.1.6. SPECT
    • 8.1.7. Ultrasound
    • 8.1.8. Photoacoustic Imaging

9. Preclinical Imaging Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Oncology
    • 9.1.3. Neurology
    • 9.1.4. Cardiology
    • 9.1.5. Infectious Diseases
    • 9.1.6. Others

10. Preclinical Imaging Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Modality, 2024 & 2032 (%)
    • 10.1.2. Pharmaceutical & Biotechnology Companies
    • 10.1.3. Contract Research Organizations (CROs)
    • 10.1.4. Academic & Research Institutes
    • 10.1.5. Others

11. Preclinical Imaging Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Preclinical Imaging Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Preclinical Imaging Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Preclinical Imaging Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Preclinical Imaging Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Preclinical Imaging Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Preclinical Imaging Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Aspect Imaging Ltd.
    • 12.2.2. BIONANO GENOMICS, INC.
    • 12.2.3. Biospace Lab S.A.
    • 12.2.4. Bruker Corporation
    • 12.2.5. Canon Medical Systems Corporation
    • 12.2.6. CubiX Imaging, Inc.
    • 12.2.7. FUJIFILM VisualSonics Inc.
    • 12.2.8. GE HealthCare Technologies Inc.
    • 12.2.9. Mediso Ltd.
    • 12.2.10. MILabs B.V.
    • 12.2.11. MinFound Medical Systems Co., Ltd.
    • 12.2.12. MR Solutions Group Ltd.
    • 12.2.13. Nanoscan Imaging Ltd.
    • 12.2.14. PerkinElmer Inc.
    • 12.2.15. Philips International B.V.
    • 12.2.16. Revvity, Inc.
    • 12.2.17. Siemens Healthineers AG
    • 12.2.18. Sofie Biosciences, Inc.
    • 12.2.19. TriFoil Imaging, Inc.
    • 12.2.20. Trifoil Imaging, Inc.
    • 12.2.21. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제